Selected Publications

Saine ME, Gizaw M, Carbonari DM, Newcomb CW, Roy JA, Cardillo S, Esposito DB, Bhullar H, Gallagher AM, Strom BL, Lo Re V 3rd: Validity of diagnostic codes to identify hospitalizations for infections among patients treated with oral anti-diabetic drugs. Pharmacoepidemiology & Drug Safety 2018, in press.

Roy J, Lum KJ, Zeldow B, Dworkin JD, Lo Re III V, Daniels MJ: Bayesian nonparametric generative models for causal inference with missing at random covariates. Biometrics 2018, in press.

Lewis JD, Scott FI, Brensinger CM, Roy JA, Osterman MT, Mamtani R, Bewtra M, Chen L, Yun H, Xie F, Curtis JR.: Increased mortality rates with prolonged corticosteroid therapy when compared with antitumor necrosis factor-α-directed therapy for inflammatory bowel disease. American Journal of Gastroenterology 2018, in press.

Shou H, Hsu JY, Xie D, Yang W, Roy J, Anderson AH, Landis JR, Feldman HI, Parsa A, Jepson C, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: Analytic considerations for repeated measures of eGFR in cohort studies of CKD. Clinical Journal of the American Society of Nephrology 2017, In press.

Yang W, Jepson C, Xie D, Roy JA, Shou H, Hsu JY, Anderson AH, Landis JR, He J, Feldman HI, Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: Statistical methods for recurrent event analysis in cohort studies of CKD. Clinical Journal of the American Society of Nephrology 12(12): 2066-2073, Dec 2017.

Vajravelu RK, Osterman MT, Aberra FN, Roy JA, Lichtenstein GR, Mamtani R, Goldberg DS, Lewis JD, Scott FI: Indeterminate QuantiFERON-TB gold increases likelihood of inflammatory bowel disease treatment delay and hospitalization. Inflammatory Bowel Diseases 24(1): 217-226, Dec 2017.

Xie D, Yang W, Jepson C, Roy J, Hsu JY, Shou H, Anderson AH, Landis JR, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators.: Statistical methods for modeling time-updated exposures in cohort studies of chronic kidney disease. Clinical Journal of the American Society of Nephrology 12(11): 1892-1899, Nov 2017.

Lo Re Rd V, Zeldow B, Kallan MJ, Tate JP, Carbonari DM, Hennessy S, Kostman JR, Lim JK, Goetz MB, Gross R, Justice AC, Roy JA: Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection. Pharmacoepidemiology and Drug Safety 26(10): 1172-1181, Oct 2017.

Byrne DD, Tate JP, Forde KA, Lim JK, Goetz MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Bedimo R, Freiberg MS, Justice AC, Kostman JR, Roy JA, Lo Re V 3rd.: Risk of acute liver injury after statin initiation by human immunodeficiency virus and chronic hepatitis C virus infection status. Clinical Infectious Diseases 65(9): 1542-1550, Oct 2017.

Ahmad FS, Cai X, Kunkel K, Ricardo AC, Lash JP, Raj DS, He J, Anderson AH, Budoff MJ, Wright Nunes JA, Roy J, Wright JT Jr, Go AS, St John Sutton MG, Kusek JW, Isakova T, Wolf M, Keane MG, CRIC Study Investigators: Racial/ethnic differences in left ventricular structure and function in chronic kidney disease: The Chronic Renal Insufficiency Cohort American Journal of Hypertension 30(8): 822-829, Aug 2017.